The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come ... Merck would be open to picking up commercial assets as well, he added. The Gardasil move was no doubt ...
Hosted on MSN11mon
Merck to study single-dose regimen of HPV vaccine Gardasil 9Merck (NYSE:MRK) announced Wednesday plans to conduct clinical trials to evaluate the efficacy and safety of a single-dose regimen of its human papillomavirus (HPV) vaccine, Gardasil 9.
Merck (MRK) announced that the National Medical Products Administration of China approved Gardasil Vaccine for use in males 9-26 years of age to help prevent certain HPV-related cancers and diseases.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback